Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News
Copy The Link to the  Article
Harbour BioMed inks $350 million deal for rights to A167
USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Copy The Link to the  Article

Related or similar articles

View more News
November 2, 2018

Newton's First Life Sciences Incubator Set To Expand

Longtime biotech executive Jeff Behrens ventured out of the C-Suite earlier this year, opening the first life sciences-focused incubator in Newton. Now he's expanding the project amid broader demand for shared lab space.
Labshares News
April 25, 2024

Laboratory Space for Emerging Biotechs:  Best Practices and Tips from Labshares 

Labshares News
May 9, 2019

Labshares Newton Selects Savran Technologies as Winner of First Launch@Labshares Competition Valued at $50K

Second Launch@Shares Competition Announced in Collaboration with MTTC/MALSI Conference and MassBio’s MassCONNECT Program
Press Releases